Urethral cancer has no single signature look, which is part of what makes it dangerous. In its earliest stages it can resemble a small, fleshy bump at the urethral opening that looks a lot like a benign growth. As it progresses, it tends to become a firm, sometimes ulcerated mass that may bleed on contact. The appearance varies with the tumor’s cell type, its location along the urethra, and whether the patient is male or female. Because these visual features overlap heavily with common, harmless conditions, urethral cancer is frequently misdiagnosed or caught late.
What You Might See at the Urethral Opening
When urethral cancer develops near the external opening of the urethra (the meatus), it sometimes shows up as a visible mass. In women, this is the most common scenario: a fleshy growth protruding from or around the urethral meatus, often reddish or pink, sometimes with an irregular surface. Early-stage tumors at the meatus can look almost identical to a urethral caruncle, which is a small, benign, raspberry-like growth that is extremely common in postmenopausal women. The resemblance is close enough that case reports document cancers being mistaken for caruncles and treated conservatively for months before anyone performs a biopsy.1Journal of Case Reports and Images in Obstetrics and Gynecology. Primary urethral carcinoma mistaken as a caruncle: A case report
As a tumor grows, it develops features that distinguish it from benign lesions. Malignant growths tend to be fixed in place rather than mobile, have a nodular or uneven surface, may ulcerate and bleed easily, appear heterogeneous in color and texture, and reach a larger size than a typical caruncle.1Journal of Case Reports and Images in Obstetrics and Gynecology. Primary urethral carcinoma mistaken as a caruncle: A case report Some urethral cancers project outward on a stalk-like base. One case of urethral melanoma, for example, presented as a darkly pigmented, stalk-like soft tissue mass growing out of the urethral meatus.2Journal of Urology and Nephrology Open Access. Female Urethral Melanoma: 2 Year Follow-Up with Bladder Sparing Approach That dark pigmentation immediately sets melanoma apart from the more common pinkish-red tumors, but urethral melanoma is exceptionally rare.
In men, visualizing the tumor is harder because much of the urethra runs through the penis and is not directly visible. When a tumor develops near the tip, it can show up as a lump or bleeding at the meatus, or as a palpable hard spot within the penis. Deeper tumors, in the part of the urethra surrounded by the prostate or running behind the scrotum, produce no visible external mass at all and are found only through internal examination or imaging.
Symptoms That Point to Something Abnormal
Because many urethral cancers sit inside the urethral canal where nobody can see them, symptoms often matter more than visible appearance. The range of complaints is broad and nonspecific, which is another reason the cancer is easy to miss. Symptoms can include painful urination, blood in the urine, pain during intercourse, perineal pain, difficulty emptying the bladder, or overflow incontinence.3PubMed Central. Female primary urethral carcinoma: A rare case report None of these symptoms is specific to cancer. Urinary tract infections, strictures, and benign growths all produce the same complaints, which is why clinicians stress that any persistent urethral symptom warrants further workup.4PubMed. Urethral Cancer
Blood at the meatus or blood-tinged urine is probably the single most important warning sign, especially when it keeps recurring without a clear cause like an infection. A lump you can feel in the perineum or along the shaft of the penis, or a palpable mass along the vaginal wall, also warrants immediate investigation. In advanced cases, tumors can enlarge enough to extend upward into the bladder or downward into the vaginal tissue.5OncoLink. Urethral Cancer
Why the Tumor’s Cell Type Changes Its Appearance
Not all urethral cancers look the same under a microscope, and the cell type influences both the surface appearance and the tumor’s behavior. The most common subtype is urothelial carcinoma, which accounts for roughly half to two-thirds of cases. Squamous cell carcinoma makes up about a fifth, and adenocarcinoma accounts for around one in seven.6European Urology Oncology. European Association of Urology Guidelines on Primary Urethral Carcinoma—2020 Update In women specifically, clear cell carcinoma is another subtype that shows up in a meaningful fraction of cases.7PubMed Central. Primary Female Urethral Carcinoma: Proposed Staging Modifications Based on Assessment of Female Urethral Histology and Analysis of a Large Series of Female Urethral Carcinomas
The subtype matters for visual appearance because different cell types originate in different parts of the urethral lining. Urothelial carcinoma tends to arise in the portion of the urethra closest to the bladder, where the lining resembles bladder tissue. Squamous cell carcinoma favors the distal (outer) portion, where the lining transitions to skin-like tissue. Adenocarcinoma can develop from glands along the urethra. On the surface, squamous tumors are more likely to appear as rough, sometimes wart-like or ulcerated growths, while urothelial tumors can look like the papillary (frond-like) or flat lesions you would see inside the bladder. None of these distinctions are reliable enough for visual diagnosis alone; a biopsy is always needed to confirm the type.
What Imaging Reveals
MRI is the most useful imaging tool for urethral cancer because of its ability to distinguish soft tissue layers. On MRI, the normal urethra has a layered structure, and a tumor shows up as a mass that disrupts that layered pattern. MRI can also reveal how far the cancer has spread into surrounding tissue, which is critical for planning treatment. In women, disruption of the normal zonal anatomy of the urethral wall indicates that the tumor has extended beyond the urethra itself.8PubMed Central. Magnetic resonance imaging of solid urethral and peri-urethral lesions
A special scenario involves cancers that develop inside a urethral diverticulum, which is a pouch or outpouching of the urethral wall. These are almost exclusively found in women. On MRI, a diverticulum normally looks like a fluid-filled sac adjacent to the urethra. When cancer develops inside one, the imaging shows a mass within that sac, sometimes with enhancement after contrast dye is given. The combination of gadolinium-enhanced MRI and biopsy through the vaginal wall or urethra is considered the best diagnostic approach for these hidden cancers.9PubMed Central. Urethral diverticulum carcinoma in females—a case series and review of the English and Japanese literature In one documented case, MRI flagged changes consistent with a diverticulum but also suspected a tumor, and biopsy through the urethra confirmed a poorly differentiated adenocarcinoma.10PubMed Central. Female urethral diverticular carcinoma: a case report and review of the literature
The Caruncle Confusion and Other Lookalikes
The resemblance between early urethral cancer and a caruncle deserves its own attention because it is the single most common diagnostic pitfall in women. Caruncles are the most frequently encountered benign lesion of the female urethra. They typically appear as small, soft, red, fleshy bumps at the urethral meatus and are especially common after menopause, when declining estrogen thins the urethral lining. Most are painless or mildly irritating and are treated with topical estrogen or left alone.
The problem arises because an early-stage urethral carcinoma sitting right at the meatus can look nearly identical. One published case describes a woman whose cancer was managed as a caruncle until it grew large enough to raise suspicion.1Journal of Case Reports and Images in Obstetrics and Gynecology. Primary urethral carcinoma mistaken as a caruncle: A case report Features that should push a clinician toward biopsy include a mass that is fixed rather than soft and mobile, a surface that is ulcerated or irregular, a size that keeps growing, or symptoms that do not improve with standard treatment. Even without those red flags, excision and pathological examination is sometimes recommended for any meatal lesion causing persistent symptoms that do not respond to conservative therapy.1Journal of Case Reports and Images in Obstetrics and Gynecology. Primary urethral carcinoma mistaken as a caruncle: A case report
Other conditions that can mimic the appearance of urethral cancer include mucosal prolapse, where the urethral lining protrudes outward; benign polyps; condylomata (genital warts); and urethral stricture tissue. In men, a stricture in particular can mask a developing cancer because strictures cause chronic irritation that itself is a recognized risk factor for urethral carcinoma.11PubMed. Primary carcinoma of the male urethra developing after urethroplasty for stricture This means that a man with a known urethral stricture who develops new or worsening symptoms should have the possibility of cancer specifically considered.
The HPV Connection
High-risk strains of human papillomavirus have been found in a substantial fraction of urethral cancers. One large pathological study detected high-risk HPV in about a third of primary urethral carcinomas, an observation that has led researchers to classify a subset of these tumors as a distinct HPV-driven entity.12PubMed Central. Carcinoma of the urethra This link is strongest for squamous cell carcinomas of the distal urethra, the region where the lining is most similar to genital skin.
In a striking recent case, a squamous cell carcinoma arose from what initially appeared to be a garden-variety urethral caruncle in a woman. Molecular testing identified HPV subtype 39 driving the cancer, and p16 immunostaining was strongly positive, a finding used as a marker for HPV involvement.13International Journal of Surgery Case Reports. HPV-associated squamous cell carcinoma in situ arising from urethral caruncle: A case of the unusual occurrence in the common urogenital lesion This was described as the first documented case of an HPV-driven cancer developing in a caruncle, and it reinforces the point that even seemingly benign meatal lesions can harbor malignancy. For a reader, the practical takeaway is that HPV vaccination, already recommended for preventing cervical and other genital cancers, may carry additional protective value against this rare malignancy, though no specific studies have confirmed that yet for urethral cancer.
How Advanced Disease Presents
When urethral cancer is caught late, the picture changes. A locally advanced tumor may form a large, firm, sometimes fungating mass visible externally or palpable through the vaginal wall or perineum. Ulceration and foul-smelling discharge become more common. The cancer can obstruct the urethra enough to cause complete inability to urinate, or it can erode into surrounding structures.
Lymph node involvement is not uncommon at diagnosis. In one analysis of patients with primary urethral carcinoma, about 28% already had clinically positive lymph nodes at the time they were diagnosed, and about 12% had distant metastases.14PubMed. Recurrence patterns in primary urethral carcinoma: Prognostic impact of inguinal and pelvic lymphadenectomy Enlarged lymph nodes in the groin are sometimes the finding that first brings a patient to medical attention. Advanced tumors in men can destroy the external genitalia or form abscesses along the tract of the urethra.
What a Urine Sample Can Show
Before any imaging or biopsy, some urethral cancers leave clues in a routine urine sample. Clear cell carcinoma of the urethra, for instance, sheds characteristic cells into the urine that can be identified by a pathologist examining the sediment under a microscope. These cells appear enlarged, with abundant clear or wispy cytoplasm, small bubble-like vacuoles, and prominent nuclei with visible nucleoli. Some cells take on a hobnail or signet-ring shape. These features are distinctive enough that researchers have concluded clear cell carcinoma of the urethra can be diagnosed through urine cytology alone when the findings are classic.15Diagnostic Cytopathology. Cytologic features of clear cell carcinoma of the urethra and urinary bladder This is not the case for all subtypes, though. Urothelial and squamous cell cancers may shed abnormal cells too, but the findings overlap more with other conditions, making urine cytology less reliable as a standalone diagnostic test for those subtypes.
How Radiation Changes What the Urethra Looks Like
Patients who have had radiation therapy for prostate cancer sometimes develop changes in the urethra that can be confusing on follow-up imaging. After radiation, the urethra tends to shorten measurably and the urethral wall can show increased signal intensity on MRI in over half of patients.16PubMed Central. MRI findings of radiation-induced changes in the urethra and periurethral tissues after treatment for prostate cancer Brachytherapy, in which radioactive seeds are implanted directly into the prostate, causes more shortening than external beam radiation. These post-treatment changes can look worrisome on MRI and need to be distinguished from a new or recurrent tumor. A radiologist familiar with the expected appearance of post-radiation tissue can usually tell the difference, but it is one more scenario where the urethra’s appearance is not straightforward.
Dogs as a Surprising Research Window
One unexpected avenue for understanding how urethral cancer looks and behaves comes from veterinary medicine. Dogs develop spontaneous urothelial carcinoma of the bladder and urethra at meaningful rates, and the tumors closely resemble the human versions both in appearance under the microscope and in their biological behavior. A study comparing 260 cases of untreated canine bladder and urethral cancer against human data found that the histological appearance was strikingly similar, including rare subtypes that had never before been described in a non-experimental animal species.17PubMed Central. The dog as an animal model for bladder and urethral urothelial carcinoma: Comparative epidemiology and histology Both species showed strong sex-based differences in who gets the cancer and where it appears. This parallel makes dogs a valuable model for testing new treatments before human trials, which matters for a cancer rare enough that assembling large clinical trials in people is extremely difficult.